NEWS

2025/04/18Press Release
Expo 2025 Osaka, Kansai is now in full swing! Algal Bio is pleased to announce its participation in the “Reborn Challenge” from May 6 (Tuesday) to May 12 (Monday) at Osaka Healthcare Pavilion.
2025/03/27Press Release
Algal Bio has acquired the management rights to the EBIS Algae Research Institute, Inc. For more information, please refer to the press release:
2025/03/21Press Release
Algal Bio won the third place in the first “Kering Generation Award X Japan”
2025/03/05Press Release
We have agreed with BLCP Power, a leading IPP operator in Thailand, to start joint research on the demonstration of CO2 fixation technology using microalgae. For more information, please refer to the press release.
2025/02/04Press Release
On January 28-29, we participated in the “Minmachi ®️SHOP” held by Obayashi Corporation and Nittetsu Kowa Real Estate in the Shinagawa area. To demonstrate its benefits on wellbeing, office workers tried the algae supplement ‘Moneru’.
2024/12/05Press Release
Now you can take Algae supplement ‘Moneru’ in tablet form! For more information, refer to the press release.
2024/12/02Press Release
We are very honored to announce that Algal Bio has been selected in the SDG/ESG field of “100 Companies Creating the Market of the Future [2025 edition]” issued today by Nikkei XTrend.
2024/11/27Press Release
“SO-Colored”, a joint project with we+, will make its debut at DESIGNTIDE TOKYO 2024. Please see the press release for details.
2024/10/01Press Release
At the Innovation Field Kashiwanoha, where many IT companies gather, we conducted a demonstration experiment on the effects of our algae supplement ‘Moneru’ on improving sleep and work performance.
Feel free to contact us through our CONTACT page if you are considering health management for your company.
2024/09/25Press Release
【Algae Supplement Moneru】 We exhibited a booth at the International Symposium on Nutritional Medicine 2024 held on September 15-16, 2024, and introduced Moneru to medical and healthcare professionals. For details, please see the press release.